Kontrast Madde Nefrotoksisitesi

1. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997; 103:368-75.
2. Morcos SK, Thomsen HS, Webb JAW. Contrast media induced nephrotoxicity: a consensus report. Eur Radiol 1999;9: 1602-13.
3. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39:930-936.
4. Liss P, Nygren A, Erikson U, Ulfendahl HR. Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int 1998;53:698-702.
5. Zager RA, Johnson AC, Hanson SY. Radiographic contrast media-induced tubular injury: evaluation of oxidant stress and plasma membrane integrity. Kidney Int 2003;64:128-139
6. Yano T, Itoh Y, Sendo T, Kubota T, Oishi R. Cyclic AMP re¬verses radiocontrast media-induced apoptosis in LLC-PK1 cells by activating A kinase/PI3 kinase. Kidney Int 2003;64:
2052-2063.
7. Briguori C, Tavano D, Colombo A. Contrast agent associated nephrotoxicity. Prog Cardiovasc Dis 2003;45:493-503.
8. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterizati-on in patients 70 years of age or older. Arch Intern Med 1995;
150:1237-42.
9. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of cont¬rast media associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coro¬nary angioplasty. Arch Intern Med 2002;162:329-336.
10. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-in¬duced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989;320:143-149.
11. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failu¬re after coronary intervention: incidence, risk factors, and re¬lationship to mortality. Am J Med 1997;103:368-375.
12. Muntner P, Coresh J, Klag MU, et al. Exposure to radiologic contrast media and an increased risk of treated end stage re¬nal disease. Am J Med Sci 2003;326:353-359.
13. Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC. Risks for re¬nal dysfunction with cardiac angiography. Ann Intern Med 1986;104:501-504.
14. Gussenhoven MJ, Ravensbergen J, van Bockel JH, Feuth JD, Aarts JC. Renal dysfunction after angiography; a risk factor analysis in patients with peripheral vascular disease. J Cardi-ovasc Surg (Torino) 1991;32:81-86.
15. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ,
et al. Incidence and prognostic importance of acute renal fa¬ilure after percutaneous coronary intervention. Circulation 2002;105:2259-2264.
16. Davidson CJ, Laskey WK, Hermiller JB, et al. Randomized tri¬al of contrast media utilization in high-risk PTCA: the COURT
trial. Circulation 2000;101:2172-7.
17. Berns AS. Nephrotoxicity of contrast media. Kidney Int 1989;
36:730-740.
18. Ogi M, Iwase N, Kitamura T, et al. Risk factors for contrast nephropathy in diabetic patients undergoing cardioangiog-
raphy. Nippon Jinzo Gakkai Shi 1993;35:161-70.
19. Barrett BJ, Carlisle EJ. Meta-analysis of the relative nephroto-xicity of high- and low-osmolality iodinated contrast media.
Radiology 1993;188:171-178.
20. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high risk patients undergoing angiography. N Engl J Med
2003;348:491-499.
21. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and nonionic cont¬rast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995;47:254-261.
22. Anderson S, Meyer TW, Rennke HG, et al. Control of glome-rular hypertension limits glomerular injury in rats with redu¬ced renal mass. J Clin Invest 1985;76:612-9.
23. Cochran ST, Wong WS, Roe DJ. Predicting angiography indu¬ced acute renal function impairment: clinical risk model. Am J Roentgenol 1983;141:1027-33.
24. Eisenberg RL, Bank WO, Hedgock MW. Renal failure after major angiography can be avoided with hydration. Am J Ro-
entgenol 1981;136:859-861.
25. Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxi-
city. Nephron Clin Pract 2003;93:C29-C34.
26. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS,
Kowalchuk GJ, et al. Prevention of contrast-induced nephro-pathy with sodium bicarbonate: a randomized controlled tri¬al. JAMA 2004;291:2328-2334.
27. Tepel M, Van Del Giet M, Schwarzfeld NR, et al. Prevention of radiographic contrast agent induced reductions in renal
function by acetylcystein. N Engl J Med 2000;343:180-184.
28. Baker CSR, Wragg A, Kumar S, et al. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAP-
PID study. J Am Coll Cardiol 2003;41:2114-2118.
29. Briguori C, Colombo A, Violante A, et al. Standard vs doub¬le dose of N-acetylcysteine to prevent contrast agent associ¬ated nephrotoxity. Eur Heart J 2004;25:206-211.
30. Pannu N, Manns B, Lee H, Tonelli M. Systematic review of the impact of N-acetylcystein on contrast nephropathy. Kid¬ney Int 2004;65:1366-1374.
31. Vogt B, Ferrari P, Schönholzer C, et al. Prophylactic hemodi-alysis after radiocontrast media patients with renal insuffici¬ency is potentially harmful. Am J Med 2001;111: 692-698.
32. Heyman SN, Brezis M, Epstein FH, et al. Early renal medul¬lary hypoxic injury from radiocontrast and indomethacin.
Kidney Int 1991;40:632-642.
33. Russo D, Minutolo R, Cianciaruso B, et al. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 1995;6:1451-1458.
54
Türk Nefroloji Diyaliz ve Transplantasyon Dergisi /Official Journal of the Turkish Society of Nephrology
Kontrast Madde Nefrotoksisitesi £
34. Gabutti L, Marone C, Monti M, et al. Does continuous veno-venous hemodiafiltration concomitant with radiological pro¬cedures provide a significant and safe removal of the iodina-ted contrast ioversol? Blood Purif 2003;21(2):152-157.
35. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of sa¬line, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med
1994;331:1416-1420.
36. Stevens MA, McCullough PA, Tobin KJ, Speck JP, Westveer
DC, Guido-Allen DA, et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the PRINCE Study. Prevention of Ra-diocontrast Induced Nephropathy Clinical Evaluation. J Am
Coll Cardiol 1999;33:403-411.
37. Stone GW, McCullough PA, Tumlin JA, et al. Fenoldopam
mesylate for the prevention of contrast-induced nephropathy:
a randomized controlled trial. JAMA 2003;290:2284-2291.
38. Wang YX, Jia
YF
, Chen KM, Morcos SK. Radiographic cont¬rast media induced nephropathy: experimental observations and the protective effect of calcium channel blockers. Br J Radiol 2001;74:1103-1108.
39. Duan SB, Liu FY, Luo JA, Wu HW, Liu RH, Peng YM, et al.
Nephrotoxicity of high- and low-osmolar contrast media. The protective role of amlodipine in a rat model. Acta Radiol
2000;41:503-507.
40. Neumayer HH, Junge W, Kufner A, Wenning A. Prevention of radiocontrast-media-induced nephrotoxicity by the calci¬um channel blocker nitrendipine: a prospective randomised
clinical trial. Nephrol Dial Transplant 1989;4:1030-1036.
41. Carraro M, Mancini W, Artero M, Stacul F, Grotto M, Cova M, et al. Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administrati¬on. Nephrol Dial Transplant 1996;11:444-448.
42. Spangberg-Viklund B, Berglund J, Nikonoff T, Nyberg P, Skau T, Larsson R. Does prophylactic treatment with felodi-pine, a calcium antagonist, prevent low-osmolar contrast-in¬duced renal dysfunction in hydrated diabetic and nondiabe-tic patients with normal or moderately reduced renal functi¬on? Scand J Urol Nephrol 1996;30:63-68.
43. Arici M, Usalan C, Altun B, Erdem Y, Yasavul U, Turgan C, et al. Radiocontrast-induced nephrotoxicity and urinary alp-ha-glutathione S-transferase levels: effect of amlodipine ad¬ministration. Int Urol Nephrol 2003;35:255-261.
44. Spargias K, Alexopoulos E, Kyrzopoulos S, Iacovis P, Green¬wood DC, Manginas A, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction un¬dergoing coronary angiography or intervention. Circulation
2004;110:2837-2842.
Official